FORTUM FOR INJECTION 1 gvial

Ülke: Singapur

Dil: İngilizce

Kaynak: HSA (Health Sciences Authority)

Aktif bileşen:

CEFTAZIDIME PENTAHYDRATE EQV CEFTAZIDIME

Mevcut itibaren:

GLAXOSMITHKLINE PTE LTD

ATC kodu:

J01DD02

Doz:

1 g/vial

Farmasötik formu:

INJECTION, POWDER, FOR SOLUTION

Kompozisyon:

CEFTAZIDIME PENTAHYDRATE EQV CEFTAZIDIME 1 g/vial

Uygulama yolu:

INTRAVENOUS, INTRAMUSCULAR

Reçete türü:

Prescription Only

Tarafından üretildi:

GLAXOSMITHKLINE MANUFACTURING SPA [VERONA]

Yetkilendirme durumu:

ACTIVE

Yetkilendirme tarihi:

1988-05-10

Bilgilendirme broşürü

FORTUM ™ 
CEFTAZIDIME

QUALITATIVE AND QUANTITATIVE COMPOSITION 
_FORTUM_ injection contains 500 mg, 1 g or 2 g of ceftazidime
(as pentahydrate).  
Ceftazidime pentahydrate is formulated in a mixture with
sodium carbonate. When 
constituted, this mixture provides a solution
of ceftazidime sodium._ _
PHARMACEUTICAL FORM 
Powder for injection/infusion 
CLINICAL PARTICULARS 
INDICATIONS 
Treatment of single or multiple infections caused
by susceptible organisms. 
May be used
alone as first choice drug before the results of sensitivity tests are available. 
May be used in combination with an
aminoglycoside or most other beta-lactam 
antibiotics. 
May be used with an antibiotic against anaerobes when
the presence of Bacteroides 
fragilis is suspected. 
Susceptibility to _FORTUM_ will vary with geography and time and
local susceptibility 
data should be consulted where available
(see _Pharmacological properties, _
_Pharmacodynamic effects_). 
Indications include: 
-  severe infections e.g. 
- 
septicaemia, bacteraemia, peritonitis, meningitis 

- 
infections in immunosuppressed patients 

- 
infections in patients in intensive care, e.g. infected 

burns 
-  respiratory tract infections including lung infections in
cystic fibrosis 
-  ear, nose and throat infections 
-  urinary tract infections 

-  skin and soft tissue infections 
-  gastrointestinal, biliary and abdominal infections 
-  bone and joint infections 
-  infections associated with haemo- and peritoneal dialysis and
with continuous 
ambulatory peritoneal dialysis (CAPD) 
-  prophylaxis: prostatic surgery (transurethral resection). 
DOSAGE AND ADMINISTRATION 
Dosage depends upon the severity, sensitivity, site and
type of infection and upon the age 
and renal function of the patient. 
Use _FORTUM_ injection by intrav

Ürün özellikleri

FORTUM ™
CEFTAZIDIME
QUALITATIVE AND QUANTITATIVE COMPOSITION
_FORTUM_
injection contains 500 mg, 1 g or 2 g of ceftazidime (as
pentahydrate).
Ceftazidime pentahydrate is formulated in a mixture with sodium
carbonate. When
constituted, this mixture provides a solution of ceftazidime sodium.
_ _
PHARMACEUTICAL FORM
Powder for injection/infusion
CLINICAL PARTICULARS
INDICATIONS
Treatment of single or multiple infections caused by susceptible
organisms.
May be used alone as first choice drug before the results of
sensitivity tests are available.
May be used in combination with an aminoglycoside or most other
beta-lactam
antibiotics.
May be used with an antibiotic against anaerobes when the presence of
Bacteroides
fragilis is suspected.
Susceptibility to
_FORTUM_
will vary with geography and time and local susceptibility
data should be consulted where available (see
_Pharmacological properties, _
_Pharmacodynamic effects_
).
Indications include:
-
severe infections e.g.
-
septicaemia, bacteraemia, peritonitis, meningitis
-
infections in immunosuppressed patients
-
infections in patients in intensive care, e.g. infected
burns
-
respiratory tract infections including lung infections in cystic
fibrosis
-
ear, nose and throat infections
-
urinary tract infections
-
skin and soft tissue infections
-
gastrointestinal, biliary and abdominal infections
-
bone and joint infections
-
infections associated with haemo- and peritoneal dialysis and with
continuous
ambulatory peritoneal dialysis (CAPD)
-
prophylaxis: prostatic surgery (transurethral resection).
DOSAGE AND ADMINISTRATION
Dosage depends upon the severity, sensitivity, site and type of
infection and upon the age
and renal function of the patient.
Use
_FORTUM_
injection by intravenous (i.v.) or by deep intramuscular ( i.m.)
injection.
Recommended i.m. injection sites are the upper outer quadrant of the
gluteus maximus or
lateral part of the thigh.
_FORTUM_
solutions may be given directly into the vein or introduced into the
tubing of a
giving set if the patient is re